1. Home
  2. FCF vs ANIP Comparison

FCF vs ANIP Comparison

Compare FCF & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Commonwealth Financial Corporation

FCF

First Commonwealth Financial Corporation

HOLD

Current Price

$21.36

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$76.67

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCF
ANIP
Founded
1934
2001
Country
United States
United States
Employees
1589
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
1994
1999

Fundamental Metrics

Financial Performance
Metric
FCF
ANIP
Price
$21.36
$76.67
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$19.75
$110.00
AVG Volume (30 Days)
849.2K
325.0K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
2.94%
N/A
EPS Growth
5.76
419.23
EPS
0.81
2.32
Revenue
N/A
$206,547,000.00
Revenue This Year
$16.32
$21.01
Revenue Next Year
$6.25
$17.59
P/E Ratio
$26.56
$32.76
Revenue Growth
N/A
2.47
52 Week Low
$15.00
$70.15
52 Week High
$22.34
$99.50

Technical Indicators

Market Signals
Indicator
FCF
ANIP
Relative Strength Index (RSI) 53.20 44.37
Support Level $21.10 $72.18
Resistance Level $21.41 $83.43
Average True Range (ATR) 0.37 2.50
MACD -0.07 -0.22
Stochastic Oscillator 24.70 33.58

Price Performance

Historical Comparison
FCF
ANIP

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: